Bioceres Crop Solutions Corp. · NASDAQ:BIOX
Bioceres Crop Solutions — Q1 2026 Earnings Presentation
13 slides from Bioceres Crop Solutions's earnings presentation, Nov 13, 2025
Slide 1: Fiscal First Quarter 2026
Fiscal First Quarter 2026 November 2025
Slide 2: Disclaimer
BIOCERES CROP SOLUTIONS Disclaimer Industry and Market Data Unless otherwise noted, the forecasted industry and market data contained in the assumptions for the projections are based upon the Company’s management estimates For example, other companies may calculate non-IFRS measures differently, or
Slide 3: Key Business & Financial Highlights
BIOCERES CROP SOLUTIONS Key Business & Financial Highlights ● Total revenues were $77.5 million in 1Q26, a 17% decline year over year, reflecting the expected reduction from the seed model transition and the pruning of low-margin and working-capital- intensive sales. ● Gross margin was 47%, driven b
Slide 4: Business Priorities
BIOCERES CROP SOLUTIONS Business Priorities Margin Expansion Reduced Operating Expenses Working Capital Management • Gross margin expanded significantly $5.9 M reduction in Opex YoY1 • Working capital continued to improve YoY and sequentially • More profitable product mix (shift away from Variable e
Slide 5: 1Q26 Revenue by Segment
BIOCERES CROP SOLUTIONS 1Q26 Revenue by Segment 1Q26 Revenue Bridge Key Drivers ($ Million) ($ Million) 12.6 93.2 (7.9) Revenue performance in line with previously -37% communicated strategy: expected reduction (7.2) from the seed model transition and the (0.6) 77.5 pruning of low-margin and working
Slide 6: 1Q26 Gross Profit by Segment
BIOCERES CROP SOLUTIONS 1Q26 Gross Profit by Segment 1Q26 1Q26 Gross Profit Bridge Key Drivers ($ Million) 7.5 37.5 (1.0) 0.5 Despite lower revenues, gross profit declined +7% (0.8) 36.2 only slightly, reflecting a more profitable product mix and reduced contribution from low-margin downstream seed
Slide 7: 1Q26 Adjusted EBITDA
BIOCERES CROP SOLUTIONS 1Q26 Adjusted 1Q26 EBITDA1 ($ Million) 0.9 (0.6) 5.9 13.6 Adj. EBITDA increased 61% YoY. A more profitable product mix, together with tighter operating discipline, translated into stronger 8.5 (1.1) operating performance. Adj. EBITDA1 Gross Profit2 Opex JV results Other incom
Slide 8: Balance Sheet & Cash Position
BIOCERES CROP SOLUTIONS Balance Sheet 4Q25 ($ Million) ($ Million) 1Q26 ($ Million) & Cash Position Net Debt Net Debt 8.0x 6.8x Adj. EBITDA1 Adj. EBITDA1 225.5 225.9 222.0 188.7 Capital Structure Update Accelerated Debt Accelerated Debt 102.3* 103.6* Acceleration notice received from noteholders *In
Slide 9: Exhibits
BIOCERES CROP SOLUTIONS Exhibits
Slide 10: Unaudited Consolidated Statement of Comprehensive Income
BIOCERES CROP SOLUTIONS Three-month period Three-month period Unaudited ended 9/30/2025 ended 9/30/2024 Revenues from contracts with customers 77.3 92.6 Consolidated Initial recognition and changes in the fair value of biological assets at the point of harvest 0.2 0.7 Cost of sales (41.3) (55.8) Gro
Slide 11: Unaudited Consolidated Statement of Financial Position
BIOCERES CROP SOLUTIONS ASSETS 9/30/2025 06/30/2025 LIABILITIES 9/30/2025 06/30/2025 Unaudited CURRENT ASSETS Cash and cash equivalents 15.5 32.7 CURRENT LIABILITIES Trade and other payables 107.1 96.4 Consolidated Borrowings 85.1 119.7 Other financial assets 1.1 2.0 Employee benefits and social sec
Slide 12: Non-IFRS Financial Measures
BIOCERES CROP SOLUTIONS Non-IFRS Financial Measures Adjusted EBITDA The company defines adjusted EBITDA as net income/(loss) exclusive of • Other companies may calculate adjusted EBITDA and similarly titled financial income/(costs), income tax benefit/(expense), depreciation, measures differently, l
Slide 13: Contact Us: Investor Relations
Contact Us: Investor Relations Investorrelations@biocerescrops.com // Investors.biocerescrops.com
Bioceres Crop Solutions — Q1 2026 Earnings Presentation on 6ix